Finance

Lists
600511:SHA
China National Medicines Corp Ltd
CN¥27.90
+0.43%
(+0.12) 1D
Oct 30, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600511...
Open
CN¥27.75
High
CN¥28.10
Low
CN¥27.56
Mkt. cap
21.05B
Avg. vol.
4.14M
Volume
4.71M
Dividend
2.87%
Quarterly dividend
CN¥0.20
Ex-dividend date
Jun 18, 2026
P/E ratio
10.63
52-wk high
CN¥31.18
52-wk low
CN¥25.11
EPS
CN¥2.62
Shares outstanding
764.40M
No. of employees
3K
Open
CN¥27.75
High
CN¥28.10
Low
CN¥27.56
Mkt. cap
21.05B
Avg. vol.
4.14M
Volume
4.71M
Dividend
2.87%
Quarterly dividend
CN¥0.20
Ex-dividend date
Jun 18, 2026
P/E ratio
10.63
52-wk high
CN¥31.18
52-wk low
CN¥25.11
EPS
CN¥2.62
Shares outstanding
764.40M
No. of employees
3K
News stories
From web sources and news partners
About China National Medicines Corp Ltd
CEO-
Employees3.02K
FoundedDec 21, 1999
Headquarters-
SectorHealth care provider
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
13.09B
13.56B
13.17B
13.88B
Cost of goods sold
12.13B
12.73B
12.40B
12.91B
Cost of revenue
12.13B
12.73B
12.40B
12.91B
Research and development expenses
25.71M
12.76M
12.00M
10.21M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
395.22M
244.70M
279.19M
269.94M
Operating expense
426.92M
348.02M
329.71M
338.27M
Total operating expenses
12.56B
13.08B
12.73B
13.25B
Operating income
528.52M
478.71M
439.72M
630.97M
Other non operating income
3.63M
239.24K
-1.14M
5.40M
EBT including unusual items
666.40M
606.78M
536.04M
765.42M
EBT excluding unusual items
659.60M
610.48M
604.08M
774.80M
Income tax expense
132.89M
115.27M
153.31M
149.63M
Effective tax rate
19.94%
19.00%
28.60%
19.55%
Other operating expenses
36.99M
31.36M
36.10M
39.61M
Net income
504.33M
474.26M
405.51M
596.46M
Net profit margin
3.85%
3.50%
3.08%
4.30%
Earnings per share
0.66
-
-
-
Interest and investment income
137.32M
137.65M
166.87M
145.96M
Interest expense
-7.00M
-6.11M
-4.67M
-4.22M
Net interest expenses
130.32M
131.54M
162.19M
141.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
558.14M
508.33M
467.75M
660.59M
Gain or loss from assets sale
-212.18K
-
20.11K
-20.11K
Upcoming events
AI content may include mistakes. Learn more
Google apps